urokinase inhibitors (Celera)

N/A

Report date: 2025/06/20 20:01:04
NME

Base Information

Drug Nameurokinase inhibitors (Celera)
Drug Alias Nameurokinase inhibitors (Axys)APC-11852APC-15411
ClassificationSmall molecules
Mechanisms of ActionUrokinase plasminogen activator inhibitors
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelera
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A